Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Pilot Therapeutics gains license for oral retinoids

Oct. 22, 2001

Idec and Mitsubishi extend IDEC-114 collaboration

Oct. 19, 2001

Fujisawa will market Atrisone in North America

Oct. 19, 2001

FDA clears use of Allergan's Tazorac cream for treatment of acne

Oct. 18, 2001

Gliatech obtains disappointing results from MRI reevaluation of ADCON-L

Oct. 17, 2001

Dapsone development for acne and burn itch progresses at Atrix

Oct. 16, 2001

Second phase I/II clinical trial of Levulan PDT begins for treatment of Barrett's esophagus

Oct. 11, 2001

FDA and EMEA accept Amevive filing for psoriasis

Oct. 11, 2001

Karo Bio updates KB-002611 clinical development

Oct. 10, 2001

New compounds designed at Welsh university inhibit retinoic acid metabolism

Oct. 5, 2001

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...